Skip to main content
Screener/Healthcare/Biotechnology

TRVI — Trevi Therapeutics, Inc.

NASDAQ
$17.55-0.16 (-0.90%)
Mid CapUnder $20Healthcare
$5.41
$18.11
$17.34
$18.16
EPS (TTM)$-0.32
P/E Ratio-47.10
Dividend Yield—
Market Cap$2.44B
Volume2.04M
Prev Close$17.71
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$13.2M$-0.09——
Q4 '25$0-$8.3M$-0.06——
Q3 '25$0-$11.8M$-0.08——
Q2 '25$0-$12.3M$-0.09——
Q1 '25$0-$10.3M$-0.09——
Q4 '24$0-$11.4M$-0.11——
Q3 '24$0-$13.2M$-0.13——
Q2 '24$0-$12.4M$-0.12——
Get Your Daily Market Recap